2004 Compounding Pharmaceutical Companies 
STAT
DECEMBER 7, 2023
But like any pharmaceutical company with an eye toward the future, Celgene continued to seek other ways to wring profits from its development work. Not long after the patent was awarded, the company leveraged federally funded research and began investigating different forms of the compound, called Revlimid.
Eye on FDA
AUGUST 2, 2022
There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 4, 2024
4,6 Traditional Herbal Registration The Traditional Herbal Medicines Directive (Directive 2004/24/EC) is implemented in the UK by the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005 and came into force on 30 April 2011. Navigating Market Authorisation in the UK for the Pharmaceutical Industry [Internet].
PharmaShots
FEBRUARY 20, 2023
After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.
The Thyroid Pharmacist
JULY 7, 2023
In a study done in 2010, NAC and 15-Deoxy-Prostaglandin J2 (a fatty acid compound with antioxidant and anti-inflammatory properties) exerted a protective effect against autoimmune thyroid destruction in vivo. [47] 2004-0395 [36] Mutlu HH, Mutlu HH. J Clin Endocrinol Metab. 2008 Jul;93(7):2559-65. doi: 10.1210/jc.2007-2404. 2007-2404.
Expert insights. Personalized for you.
315 
Let's personalize your content